Diagnostic Cardiology at Baxter - U.S.
Mark Handfelt has a diverse work experience in various roles and companies. Mark started their career as the Senior Vice President and General Counsel at CellPro Incorporated in September 1997. Mark then served as the Acting President from September 1998 to June 1999. In June 1999, they joined Venture Law Group LLP as a Partner until August 2002. Mark then joined Wilson Sonsini Goodrich & Rosati as a Partner from August 2002 to January 2011. In January 2011, they became the President and Chief Executive Officer at LeMond Fitness until October 2013. From April 2013, they held the position of Chief Administrative Officer and General Counsel at Bardy Diagnostics, Inc. In August 2014, they joined Centriq Corporation as the Chief Business Officer and General Counsel until September 2016.
Mark Handfelt completed their Bachelor of Arts degree at the University of Iowa from 1981 to 1985. Following that, they attended the Northwestern University Pritzker School of Law from 1985 to 1988. No specific degree or field of study information was provided for their time at Northwestern University.
Diagnostic Cardiology at Baxter - U.S.
1 followers
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.